OC
AGN

Oppenheimer & Co’s Allergan plc AGN Stock Holding History

Oppenheimer & Co’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-8,876
Closed -$1.57M – 1339
2020
Q1 		$1.57M Buy
8,876
+984
+12% +$185K 0.05% 403
2019
Q4 		$1.51M Sell
7,892
-588
-7% -$106K 0.04% 490
2019
Q3 		$1.43M Sell
8,480
-753
-8% -$123K 0.04% 498
2019
Q2 		$1.55M Sell
9,233
-2,480
-21% -$343K 0.04% 463
2019
Q1 		$1.72M Buy
11,713
+6,455
+123% +$936K 0.05% 427
2018
Q4 		$703K Sell
5,258
-5,394
-51% -$884K 0.02% 631
2018
Q3 		$2.03M Buy
10,652
+5,697
+115% +$1.05M 0.05% 400
2018
Q2 		$826K Sell
4,955
-4,478
-47% -$719K 0.02% 664
2018
Q1 		$1.59M Sell
9,433
-2,670
-22% -$448K 0.04% 456
2017
Q4 		$1.98M Sell
12,103
-17,898
-60% -$3.21M 0.05% 392
2017
Q3 		$6.15M Sell
30,001
-2,825
-9% -$657K 0.16% 143
2017
Q2 		$7.98M Sell
32,826
-4,842
-13% -$1.14M 0.22% 102
2017
Q1 		$9M Sell
37,668
-1,711
-4% -$398K 0.25% 91
2016
Q4 		$8.27M Buy
39,379
+7,928
+25% +$1.64M 0.24% 97
2016
Q3 		$7.24M Buy
31,451
+5,923
+23% +$1.45M 0.21% 106
2016
Q2 		$5.9M Sell
25,528
-8,305
-25% -$1.91M 0.18% 124
2016
Q1 		$9.07M Sell
33,833
-10,827
-24% -$3.1M 0.28% 85
2015
Q4 		$14M Sell
44,660
-1,572
-3% -$468K 0.42% 50
2015
Q3 		$12.6M Buy
46,232
+218
+0.5% +$67K 0.38% 52
2015
Q2 		$14M Buy
46,014
+2,723
+6% +$812K 0.39% 53
2015
Q1 		$12.9M Buy
43,291
+10,379
+32% +$2.96M 0.35% 62
2014
Q4 		$8.47M Sell
32,912
-1,424
-4% -$356K 0.24% 100
2014
Q3 		$8.29M Buy
34,336
+28,680
+507% +$6.42M 0.25% 97
2014
Q2 		$1.26M Sell
5,656
-24,891
-81% -$5.15M 0.04% 528
2014
Q1 		$6.29M Sell
30,547
-493
-2% -$97.7K 0.19% 131
2013
Q4 		$5.21M Buy
31,040
+5,020
+19% +$785K 0.17% 152
2013
Q3 		$3.75M Buy
26,020
+17,749
+215% +$2.36M 0.13% 198
2013
Q2 		$1.04M Buy
+8,271
New +$936K 0.04% 503

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Oppenheimer & Co's AGN Position: Q2 2020 in Review

Oppenheimer & Co sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 8,876 shares — an estimated $1.57M sold.

Oppenheimer & Co first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $14M in Q2 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Oppenheimer & Co reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Oppenheimer & Co sold 8,876 Allergan plc shares in Q2 2020, an estimated $1.57M.
  • Oppenheimer & Co first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
  • Oppenheimer & Co's Allergan plc position peaked at $14M in Q2 2015.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Oppenheimer & Co's 13F filing for Q2 2020, filed 11 Aug 2020.